Molecular Targets of Disease—Changing Treatment Strategies for Parkinson's Disease
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Neurobiology".
Deadline for manuscript submissions: 31 October 2025 | Viewed by 46
Special Issue Editor
Special Issue Information
Dear Colleagues,
Efforts to target Parkinson's disease (PD) focus on several key areas, including dopamine deficiency, neuroprotection, and disease-modifying therapies that target specific proteins like alpha-synuclein and genes like GBA and LRRK2. Current therapies aim to relieve motor symptoms, but research is actively pursuing strategies that could slow or halt disease progression. Several molecular targets are being investigated for PD treatment, including protein translation regulators, ion channels, and pathways involving neuroinflammation and cellular stress. These potential therapeutic molecular targets provide opportunities for developing more effective and targeted treatments for PD.
This Special Issue will cover how these exciting potential molecular target technologies, including novel theranostic agents, stem cell transplantation, ultrasound-assisted drugs or nucleic acid delivery, biomedical applications, etc., are changing treatment strategies for PD. We expect this Special Issue to inspire more innovations in research by revealing previously used molecular targeting technologies in the search for methods that effectively treat diseases.
Dr. Chung-Yin Lin
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Parkinson’s disease
- therapeutic targets
- potential treatments
- molecular targets
- drug delivery
- neurodegenerative disease
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
